Drug combinations and all cause mortality in heart disease: No new insights were gained

BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7509.159 (Published 14 July 2005) Cite this as: BMJ 2005;331:159
  1. Staffan Bjorck, medical adviser (staffan.bjorck@vgregion.se)
  1. Department of Healthcare Evaluation, Regionens Hus, SE 54180 Skövde, Sweden

    EDITOR—Hippisley-Cox and Coupland conclude that the addition of angiotensin converting enzyme (ACE) inhibitors to combinations of drugs conferred no additional benefit in their study of patients in primary care with ischaemic heart disease.1 However, such a conclusion should be reached with caution.

    The drugs were given to the patients with …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription